Aubagio approved for multiple sclerosis
(HealthDay)—Aubagio (teriflunomide) has been approved by the U.S. Food and Drug Administration to treat adults with relapsing forms of multiple sclerosis (MS).
Sep 13, 2012
0
0
(HealthDay)—Aubagio (teriflunomide) has been approved by the U.S. Food and Drug Administration to treat adults with relapsing forms of multiple sclerosis (MS).
Sep 13, 2012
0
0
Alpha-1 antitrypsin deficiency consists of a production deficit of a protein that protects the lungs from degradation or inflammation caused by lung infections, as well as from external agents such a tobacco or pollution. ...
Aug 14, 2018
0
0
(HealthDay)—A flesh-eating bacteria has migrated into the Delaware Bay between Delaware and New Jersey, drawn north by the warmer waters of climate change, doctors say.
Jun 18, 2019
0
2
Since the 1970s, liver disease in the UK has increased by more than 400%, particularly in people under 65—in marked contrast to all other major causes of death which have been decreasing in younger age groups. This epidemic ...
Aug 22, 2019
0
2
After a surgeon stitches up a patient's abdomen, costly complications -- some life-threatening -- can occur. To cut down on these postoperative problems, Johns Hopkins undergraduates have invented a disposable suturing tool ...
Aug 16, 2012
0
0
While the risk of alcohol-related liver cirrhosis is known to increase with heavy drinking, a number of people who drink large quantities of alcohol seem to escape developing the disease. This variation in susceptibility ...
Apr 14, 2015
0
8
(AP) -- A panel of cancer experts overwhelmingly backed the approval of a GlaxoSmithKline drug for a rare type of tumor, noting there are few other treatment options for patients.
Mar 20, 2012
0
0
(HealthDay)—After reviewing data from recent large clinical trials, the U.S. Food and Drug Administration has determined that Samsca (tolvaptan) should not be used for longer than 30 days and should not be used at all by ...
May 2, 2013
0
0
Researchers from John Theurer Cancer Center at Hackensack University Medical Center, one of the nation's 50 best cancer centers, played an important role in a study published in the New England Journal of Medicine on October ...
Nov 20, 2012
0
0
UVA Health researchers have developed a powerful new tool to understand how medications affect men and women differently, and that will help lead to safer, more effective drugs in the future.
Oct 2, 2023
0
31